𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and safety of antiviral therapy in patients with Crohn's disease and chronic hepatitis C

✍ Scribed by T.-M. SCHERZER; K. STAUFER; G. NOVACEK; P. STEINDL-MUNDA; S. SCHUMACHER; H. HOFER; P. FERENCI; H. VOGELSANG

Book ID
108605406
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
70 KB
Volume
28
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Impact of disease severity on outcome of
Impact of disease severity on outcome of antiviral therapy in treatment-naΓ―ve patients with chronic hepatitis C
✍ Johan Westin; Kristoffer Hellstrand; Γ…sa AlsiΓΆ; Magdalena Ydreborg; Carlo Ferrar πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 113 KB

The results encourage a new HDV classification in which the Deltavirus genus consists of 8 major clades, 5 of them being present in Africa (i.e., clade 1, 5, 6, 7, and 8). 7 Interestingly, clade 5 isolates represent approximately 20% of HDV RNA-positive samples, which is stable for the time period i

Antiviral activity and safety of LB80380
Antiviral activity and safety of LB80380 in hepatitis B e antigen–positive chronic hepatitis B patients with lamivudine-resistant disease
✍ Man-Fung Yuen; Kwang-Hyub Han; Soon-Ho Um; Seung Kew Yoon; Hye-Ryon Kim; John Ki πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 380 KB πŸ‘ 1 views

We aimed to determine the antiviral activity and safety of a new nucleotide analogue, LB80380, in chronic hepatitis B (CHB) patients with lamivudine-resistant virus. Sixty-five patients with lamivudine-resistant virus were randomized to receive five ascending daily doses (30, 60, 90, 150, 240 mg) of

Efficacy and safety of interferon alfa t
Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes
✍ Luca Todros; Giorgio Saracco; Marilena Durazzo; Maria Lorena Abate; Giovanni Tou πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 521 KB

Interferon alfa (IFN) therapy is efficacious in chronic viral hepatitides. It may, however, cause adverse immunologic reactions in patients with concomitant autoimmune phenomena. A minority of patients with chronic type C hepatitis have antibodies against liver and kidney microsomes (anti-LKM) in se